Pooled Analysis of 86 Published Spinal Hydatid Cyst Cases From Turkey/Turkiye'den Yayinlanmis 86 Spinal Kist Hidatik Olgusunun Havuz Analizi Yontemi ile Degerlendirilmesi

Introduction: Spinal hydatid cyst (SHC) is a difficult to treat parasitic infectious disease with high risk of recurrence. Similar with HC the visceral organs, there are no standard treatment protocols for SHC. The aim of this study was to analyze clinical and laboratory findings, treatment, and pro...

Full description

Saved in:
Bibliographic Details
Published in:Mediterranean journal of infection, microbes & antimicrobials microbes & antimicrobials, 2019-01, Vol.8
Main Authors: Suntur, Bedia Mutay, Çavus, Gökhan
Format: Article
Language:English
Subjects:
Back pain
Communicable diseases
Echinococcosis
Incontinence
Mebendazole
Medical examination
Medical research
Numbness
Online databases
Prognosis
Urinary incontinence
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Spinal hydatid cyst (SHC) is a difficult to treat parasitic infectious disease with high risk of recurrence. Similar with HC the visceral organs, there are no standard treatment protocols for SHC. The aim of this study was to analyze clinical and laboratory findings, treatment, and prognosis in published SHC case reports from Turkey in the last 20 years. Materials and Methods: One national (Ulakbim, Turkish medical literature database, Results: A total of 86 cases of SHC were identified in the three databases using the specified keywords. Forty-eight (56%) of the patients were male and the mean age was 36.4[+ or -]16.8 (8-73) years. The most common presenting symptoms were back pain (83%), difficulty in walking (47%), urinary and/or stool incontinence (27%), and leg numbness (22%). Concurrent extraspinal involvement was identified in 35% of the patients while thoracic involvement was the most common (36%). Extradural intraspinal was the most common lesion type. The most preferred treatment protocol was albendazole for a duration of six months. When the history and follow-up period of the patients were evaluated together, 51% of the patients had at least one recurrence. Conclusion: SHC affects the young to middle-aged population, leading to neurological morbidities that decrease patients' quality of life. Studies are needed to determine more effective medical treatment protocols for SHC. Keywords: Echinococcus granulosus, echinococcosis, Dew/Braithwaite & Lees classification, mebendazole, systematic review
ISSN:2147-673X
2147-673X
DOI:10.4274/mjima.galenos.2019.2019.7